Ms. Morse recorded her first podcast episode in the summer of 2005 in her apartment in San Francisco. Until that point, right after graduating from the University of Michigan with a Bachelor of Arts in psychology, she had worked in politics and as a video producer, most notably helping out on the mayoral campaign of…
Lenvatinib plus pembrolizumab yields better overall survival than single-agent sunitinib when given as first-line therapy in untreated patients with metastatic kidney cancer The combination also improved progression-free survival and overall response rate BOSTON – Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients…